Examinant per Autoria "Grivas, Petros"
Resultats per pàgina
Opcions d'ordenació
Ítem Accés Obert Avelumab first-line maintenance in locally advanced or metastatic urothelial carcinoma: Applying clinical trial findings to clinical practice(Elsevier, 2021) Grivas, Petros; Agarwal, Neeraj; Pal, Sumanta; Kalebasty, Arash Rezazadeh; Sridhar, Srikala S.; Smith, Jodi; Devgan, Geeta; Sternberg, Cora N.; Bellmunt Molins, Joaquim, 1959-
Ítem Accés Obert Avelumab maintenance in advanced urothelial carcinoma: biomarker analysis of the phase 3 JAVELIN Bladder 100 trial(Nature Research, 2021) Powles, Thomas; Sridhar, Srikala S.; Loriot, Yohann; Bellmunt Molins, Joaquim, 1959-; Mu, Xinmeng Jasmine; Ching, Keith A.; Pu, Jie; Sternberg, Cora N.; Petrylak, Daniel P.; Tambaro, Rosa; Dourthe, Louis M.; Alvarez-Fernandez, Carlos; Aarts, Maureen; Di Pietro, Alessandra; Grivas, Petros; Davis, Craig B.
Ítem Accés Obert Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS)(BioMed Central, 2021) Grivas, Petros; Rodriguez-Vida, Alejo; Chowdhury, Simon
Ítem Accés Obert Targeting FGFR3 alterations with adjuvant infigratinib in invasive urothelial carcinoma: the phase III PROOF 302 trial(Future Medicine, 2022) Pal, Sumanta; Somford, Diederik M.; Grivas, Petros; Sridhar, Srikala S.; Gupta, Shilpa; Bellmunt Molins, Joaquim, 1959-; Sonpavde, Guru; Fleming, Mark T.; Lerner, Seth Paul; Loriot, Yohann; Hoffman-Censits, Jean; Valderrama, Begoña P.; Andresen, Corina; Schnabel, Marco J.; Cole, Suzanne; Daneshmand, Siamak